Register for our free email digests:
Clinical / R & D
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
TCT 2018: Abbott Expects COAPT Results To Support Expanding MitraClip's Indication
Data presented at the Transcatheter Cardiovascular Therapeutics conference Sept. 23 in San Diego will support expanding the label of Abbott's MitraClip mitral valve repair device to include secondary, or functional, mitral regurgitation, a company executive tells Medtech Insight. In the COAPT trial, MitraClip reduced the two-year rate of heart-failure hospitalization and all-cause mortality in patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation.
Clinical Trials
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Clinical Trials
TCT 2018: Next-Gen Stents, Key Insights From Leading Experts
The Transcatheter Cardiovascular Therapeutics meeting held in San Diego featured late-breaking trials of new stent technologiesincluding TALENT, BIONYX, BIOFLOW-V, SORT-OUT IX, LEADERS FREE II and ReCre8.
Starts & Stops: MedAutonomic Initiates Phoenix Neuromodulation Stomach Implant Trial; Boston Scientific Completes S-ICD Trial Enrollment
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 17 through Sept. 23, including trial announcements from Boston Scientific, MedAutonomic, Desiral, and Edwards Lifesciences.
Results Recap: Terumo PulseCath Shows Promise In High-Risk PCI; Reapplix' LeucoPatch Promotes Ulcer-Healing
Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition covers the week of Sept. 14-20, including trial announcements from Nanobiotix, Reapplix, Profound Medical, Sequana Medical, and Terumo.
New Technology
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Innovation
Starts & Stops: MedAutonomic Initiates Phoenix Neuromodulation Stomach Implant Trial; Boston Scientific Completes S-ICD Trial Enrollment
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made Sept. 17 through Sept. 23, including trial announcements from Boston Scientific, MedAutonomic, Desiral, and Edwards Lifesciences.
Results Recap: Terumo PulseCath Shows Promise In High-Risk PCI; Reapplix' LeucoPatch Promotes Ulcer-Healing
Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past week, based on information collected by Meddevicetracker. This week's edition covers the week of Sept. 14-20, including trial announcements from Nanobiotix, Reapplix, Profound Medical, Sequana Medical, and Terumo.
Global Device Approvals, Weekly Snapshot: Apple Watch Wins FDA Love
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. Tech giant Apple led this round's news with two US FDA approvals for heart-rhythm-analysis apps embedded in the new Apple Watch.
Approvals
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Approvals
Global Device Approvals, Weekly Snapshot: Transcranial Stimulator For Alzheimer's, And More
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Among the five added this week, Neuronix's NeuroAD Non Invasive Cortical Enhancer technology was approved in Australia for use in Alzheimer's patients, in combination with "tailored cognitive therapy."
Global Device Approvals, Weekly Snapshot: Apple Watch Wins FDA Love
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. Tech giant Apple led this round's news with two US FDA approvals for heart-rhythm-analysis apps embedded in the new Apple Watch.
Israeli Robotics System Steers Closer To European Market
XACT Robotics has secured a CE mark for its XACT image-guided robotic needle steering system for CT-guided percutaneous procedures in the abdomen. The company is hoping to formally launch XACT by 2019 while expanding the system to additional clinical indications, including spine, and lung procedures.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.